Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Evidence for preferential genotyping of a minority human immunodeficiency virus population due to primer-template mismatching during PCR-based amplification.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.
Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with
Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+ lymphocytes.
Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients.
[Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].